# EDGAR Filing Document

**Accession Number:** 0001870611
**File Stem:** 0001870611-26-000005
**Filing Date:** 2026-4
**Character Count:** 3036
**Document Hash:** aae4f84850483e0def50bacc6735f7a6
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001870611-26-000005.hdr.sgml**: 20260420

**ACCESSION NUMBER**: 0001870611-26-000005

**CONFORMED SUBMISSION TYPE**: C-AR

**CONFIRMING COPY**: 

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20251231

**FILED AS OF DATE**: 20260420

**DATE AS OF CHANGE**: 20260420

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** PIROUETTE PHARMA INC.
- **CENTRAL INDEX KEY:** 0001870611

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** C-AR
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 020-33478

**BUSINESS ADDRESS:**
- **STREET 1:** 200 INTERNATIONAL DRIVE
- **STREET 2:** STE 170 - 180
- **CITY:** PORTSMOUTH
- **STATE:** NH
- **BUSINESS PHONE:** (617) 545-4768

**MAIL ADDRESS:**
- **STREET 1:** 200 INTERNATIONAL DRIVE, SUITE 170
- **STREET 2:** STE 170 - 180
- **CITY:** PORTSMOUTH
- **STATE:** NH

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Pirouette Medical Inc.
- **DATE OF NAME CHANGE:** 20210701

### Attached PDF Documents

**Attachment 1:** `formc-ar.pdf`

_No text found in this document._

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM C

### UNDER THE SECURITIES ACT OF 1933

### Issuer Information

**Name of Issuer:** Pirouette Pharma Inc

**Legal Status:** Corporation

**Jurisdiction of Incorporation/Organization:** DE

**Date of Organization:** 06-08-2017

**Physical Address:** 200 International Drive, Suite 170, Portsmouth, NH, 03801

**Issuer Website:** https://pirouettepharma.com/

**Is there a Co-Issuer?:** Yes

### Offering Information

**Oversubscription Accepted:** No

### Annual Report Disclosure Requirements

**Current Number of Employees:** 17

**Total Assets (Most Recent Fiscal Year):** $4,374,437.00

**Total Assets (Prior Fiscal Year):** $3,878,452.00

**Cash & Cash Equivalents (Most Recent Fiscal Year):** $2,076,640.00

**Cash & Cash Equivalents (Prior Fiscal Year):** $1,610,924.00

**Accounts Receivable (Most Recent Fiscal Year):** $0.00

**Accounts Receivable (Prior Fiscal Year):** $0.00

**Short-Term Debt (Most Recent Fiscal Year):** $501,599.00

**Short-Term Debt (Prior Fiscal Year):** $497,330.00

**Long-Term Debt (Most Recent Fiscal Year):** $13,241,055.00

**Long-Term Debt (Prior Fiscal Year):** $7,388,869.00

**Revenues/Sales (Most Recent Fiscal Year):** $0.00

**Revenues/Sales (Prior Fiscal Year):** $0.00

**Cost of Goods Sold (Most Recent Fiscal Year):** $0.00

**Cost of Goods Sold (Prior Fiscal Year):** $0.00

**Taxes Paid (Most Recent Fiscal Year):** $0.00

**Taxes Paid (Prior Fiscal Year):** $0.00

**Net Income (Most Recent Fiscal Year):** $-5,360,471.00

**Net Income (Prior Fiscal Year):** $-4,050,003.00

### Signatures

**Issuer:** Pirouette Pharma Inc

**Signature:** Conor Cullinane

**Title:** Executive, President, CEO, Chair, and Co-Founder

---

**Signature:** Conor Cullinane

**Title:** Executive, President, CEO, Chair, and Co-Founder

**Date:** 04-20-2025